drugset / Trial / NCT00072098
Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Inserting the interleukin-12 gene into a person's cancer cells may make the body build an immune response to kill tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of interleukin-12 gene when injected into the tumors of patients with liver metastases secondary to colorectal cancer.
Timeline
- Start
- 2003-09
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | interleukin-12 | Protein / enzyme biologic | — | Other |
| Background | adenovirus vector | Unknown | — | Other |